Xtant Medical

Xtant Medical Announces Amendments to Credit Facility and Issuance of Warrants

BELGRADE, MT, Sept. 17, 2018 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE American: XTNT), a leader in the development and commercialization of regenerative medicine products and medical devices, today announced it has executed amendments to its credit facility reducing interest payable, among other provisions. Xtant has also issued warrants for the purchase of 1.2 million shares of common stock. The Company has executed the 24th and 25th amendments to its Amended and Restated Credit Agreement with its lenders. These amendments provide for the following changes, as further described in the amendments: No interest will be charged on the loan balance outstanding under the cr…